Pablo Borrega

PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer

Elena Castro, Nuria Romero-Laorden, Ángela del Pozo et al. · Journal of Clinical Oncology · 2019 · 372 citations · Full text

Medicine, Oncology, Urology +16

MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients

Angelo Gámez‐Pozo, Luis Antón-Aparicio, Cristina Bayona et al. · Neoplasia · 2012 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies

Daniel Khalaf, Isabel M. Aragón, Matti Annala et al. · Annals of Oncology · 2020 · 44 citations · Full text

Medicine, Oncology, Urology +17

Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice

Juan Antonio Virizuela, Yolanda Escobar, Javier Cassinello et al. · Clinical & Translational Oncology · 2012 · 38 citations

Medicine, Oncology, Pharmacotherapy +17

Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas

Jaime Feliú, Ramón Mel, Pablo Borrega et al. · Annals of Oncology · 2002 · 35 citations

Medicine, Oncology, Pharmacology +16